Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07536867 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of Serratus Posterior Superior Intercostal Plane Block and Rhomboid Intercostal Block in Patients Undergoing Breast Cancer Surgery

Study acronym: SPSIP-RIB
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description expanded, about 4 wordsv4
  2. Start date: Mar 30, 2026 to Aug 30, 2026v3 Show 6 more changesShow less
    • Primary completion pushed from Mar 30, 2027 to Aug 30, 2027
    • Enrollment increased: 50 → 60 participants
    • Study completion pushed from Apr 30, 2027 to Sep 30, 2027
    • Study sites: 0 to 1
    • Study description shortened, about 7 words
    • Study title shortened, about 6 words
  3. Secondary endpoints: details revised at 2 of 7 entries
    • Study title shortened, about 4 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized clinical trial aims to evaluate and compare the analgesic efficacy of the Serratus Posterior Superior Intercostal Plane (SPSIP) and Rhomboid Intercostal Block in patients undergoing Breast Cancer Surgery With Axillary Lymph Node Dissection. The primary outcome is Visual Analog Scale (VAS) during the first 24 hours after surgery. Secondary outcomes include total opioid consumption, requirement for rescue analgesia, block performance time, block-related and systemic side effects (hematoma, pneumothorax, local anesthetic toxicity, vascular puncture, infection), Patient satisfaction assessed using a Likert scale, quality of recovery assessed using the QoR-15 questionnaire.
Trial Details
NCT Number NCT07536867
Lead Sponsor Antalya City Hospital
Conditions
(from sponsor)		 Breast Cancer, Lymph Node Dissection, Postoperative Pain, Mastectomy
Related terms Breast Neoplasms, Postoperative Pain
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov